Intco Medical Technology Co., Ltd. (300677.SZ)
CNY 22.24
(-0.54%)
CNY 22.24
(-0.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.16 Billion CNY | -5.75% |
| 2022 | 1.36 Billion CNY | -84.57% |
| 2021 | 9.03 Billion CNY | 6.75% |
| 2020 | 8.51 Billion CNY | 2542.49% |
| 2019 | 326.13 Million CNY | 5.21% |
| 2018 | 300.47 Million CNY | 22.49% |
| 2017 | 240.62 Million CNY | 61.73% |
| 2016 | 150.68 Million CNY | 23.93% |
| 2015 | 120.27 Million CNY | 59.17% |
| 2014 | 78.21 Million CNY | 45.88% |
| 2013 | 51.23 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 301.88 Million CNY | 194.54% |
| 2024 Q2 | 382.8 Million CNY | 16.81% |
| 2024 Q3 | 194.77 Million CNY | -69.28% |
| 2023 Q4 | 184.26 Million CNY | 381.76% |
| 2023 Q2 | 612.66 Million CNY | 565.99% |
| 2023 Q3 | -65.39 Million CNY | -110.67% |
| 2023 FY | - CNY | -5.75% |
| 2023 Q1 | -131.47 Million CNY | -555.53% |
| 2022 Q3 | 251.35 Million CNY | -40.42% |
| 2022 Q2 | 421.9 Million CNY | 248.17% |
| 2022 FY | - CNY | -84.57% |
| 2022 Q4 | -20.05 Million CNY | -107.98% |
| 2022 Q1 | 121.17 Million CNY | -79.92% |
| 2021 Q3 | 1.14 Billion CNY | -54.29% |
| 2021 Q1 | 4.47 Billion CNY | 44.13% |
| 2021 FY | - CNY | 6.75% |
| 2021 Q4 | 603.62 Million CNY | -47.31% |
| 2021 Q2 | 2.5 Billion CNY | -43.99% |
| 2020 Q3 | 2.96 Billion CNY | 38.32% |
| 2020 FY | - CNY | 2542.49% |
| 2020 Q1 | 167.27 Million CNY | 162.34% |
| 2020 Q2 | 2.14 Billion CNY | 1182.27% |
| 2020 Q4 | 3.1 Billion CNY | 4.63% |
| 2019 Q1 | 43.12 Million CNY | -30.58% |
| 2019 Q4 | 63.76 Million CNY | -11.16% |
| 2019 Q3 | 71.77 Million CNY | 38.86% |
| 2019 Q2 | 51.68 Million CNY | 19.86% |
| 2019 FY | - CNY | 5.21% |
| 2018 Q4 | 62.12 Million CNY | -15.05% |
| 2018 FY | - CNY | 22.49% |
| 2018 Q3 | 73.12 Million CNY | 48.57% |
| 2018 Q2 | 49.22 Million CNY | 15.62% |
| 2018 Q1 | 42.57 Million CNY | 77.31% |
| 2017 FY | - CNY | 61.73% |
| 2017 Q1 | 81.75 Million CNY | 230.17% |
| 2017 Q2 | -1.77 Million CNY | -102.17% |
| 2017 Q3 | 68.71 Million CNY | 3973.12% |
| 2017 Q4 | 24.01 Million CNY | -65.06% |
| 2016 Q1 | 68.99 Million CNY | 0.0% |
| 2016 Q4 | 24.76 Million CNY | 4.82% |
| 2016 Q3 | 23.62 Million CNY | 395.91% |
| 2016 Q2 | -7.98 Million CNY | -111.57% |
| 2016 FY | - CNY | 23.93% |
| 2015 FY | - CNY | 59.17% |
| 2014 FY | - CNY | 45.88% |
| 2013 FY | - CNY | 0.0% |